Effect of interferon-α2b therapy on St. Louis viral meningoencephalitis: Clinical and laboratory results of a pilot study

Journal of Infectious Diseases

Volumn 190, Issue 6, 2004, Pages 1084-1087

  Rahal, James J ^a,b   Anderson, John ^c   Rosenberg, Carl ^a   Reagan, Teresa ^d   Thompson, Lowery Lee ^d  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CT Agricultural Experiment Station ^*  (United States)

^d Glenwood Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; VIRUS ANTIBODY;

ADULT; ARTICLE; ASSISTED VENTILATION; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIC ENCEPHALITIS; FEMALE; HEPATITIS; HUMAN; LABORATORY TEST; MALE; NEUTROPENIA; PRIORITY JOURNAL; QUADRIPLEGIA; RACE DIFFERENCE; RESPIRATORY FAILURE; ST LOUIS FLAVIVIRUS; ANIMAL; BLOOD; CELL LINE; CELL SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; HAMSTER; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED; PILOT STUDY; TIME; VIROLOGY;

ADULT; ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CRICETINAE; ENCEPHALITIS VIRUS, ST. LOUIS; ENCEPHALITIS, ST. LOUIS; FEMALE; HEPATITIS; HUMANS; INTERFERON ALFA-2B; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPENIA; PILOT PROJECTS; QUADRIPLEGIA; RESPIRATORY INSUFFICIENCY; TIME FACTORS;

EID: 4444287642     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/423325     Document Type: Article

References (9)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
2. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn D, Khanh VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry 2000; 68:405-15.
3. Anderson JF, Rahal JJ. Efficacy of interferon α-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8:107-8.
4. Tsai TF. Flaviviruses (yellow fever, dengue, dengue hemorrhagic fever, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis). In: Mandell GL, Bennett JE, Dolin R, eds. Principals and practice of infectious diseases. 5th ed. New York: Churchill Livingstone, 2000:1714-36.
5. Gardner JJ, Reyes MG. Pathology. In: Monath TP, ed. St. Louis encephalitis. Washington, DC: American Public Health Association, 1980:551-69.
6. Khakoo S, Glue P, Grellier L, et al. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol 1998; 46:563-70.
7. Jones SC, Morris J, Hill G, Alderman M, Ratard RC. St. Louis encephalitis outbreak in Louisiana in 2001. J La State Med Soc 2002; 154:303-6.
8. Leyssen P, Drosten C, Paning M, Charlier M, Paeshuyse J, DeClereq E. Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob Agents Chemother 2003; 47:777-82.
9. Merigan TC. Interferon - the first quarter century. JAMA 1982; 248: 2513-6.